Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Drug Deliv Sci Technol. 2020 Oct 6;61:102128. doi: 10.1016/j.jddst.2020.102128

Table 2.

Comparison of the thermal data for F4 and F7 formulations for the accelerated stability conditions (40 (±2) °C and 75 (±5) % RH).

Time F4
F7
Eutectic peak (Enthalpy J/g) Co-crystal peak (Enthalpy J/g) Eutectic peak (Enthalpy J/g) Co-crystal peak (Enthalpy J/g)
Initial 1.610 119.56 No eutectic 101.78
First month 4.142 110.83 No eutectic 114.43
Third month 3.016 107.95 No eutectic 103.54